跳至主要内容
临床试验/NCT06864910
NCT06864910已完成不适用

Brain Connectivity in Mild Cognitive Impairment and Alzheimer's Disease: A Resting and Task-based fMRI-MEG Study Examining Alterations in Functional Connectivity Following Treatment With Transcranial Current Stimulation (tDCS)

National Institute of Mental Health and Neuro Sciences, India2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Magnetic Resonance Imaging

研究概览

简要总结

The goal of this observational study was to examine the brain functional alterations accompanying cognitive modulatory effect of anodal transcranial Direct Current Stimulation (tDCS) in sample patients with early Alzheimer's Disease (AD), registered under Geriatric Clinic and Services at NIMHANS, and who were initiated on tDCS for cognitive enhancement. Further, to explore the potential beneficial effect of tDCS, the investigators offered the intervention to the first 40 consenting patients from the amnestic Mild Cognitive Impairment (aMCI) (n=21) and mild AD (n=19) samples. The changes in functional connectivity/activations associated with diminished cognitive functions were examined using functional magnetic resonance imaging (fMRI) and magnetoencephalography (MEG), between pre- and post-tDCS intervention. The administration of tDCS followed the standard procedures using a neuroConn DC-Stimulator Plus device (neuroCare Group GmbH, Munich, Germany) with the anode placed at F3 (left DLPFC) and the cathode over the right supraorbital region (Fp2) using 5x7cm electrodes. The anodal tDCS intervention involved daily sessions (between 10-11 a.m.) for 10 consecutive days, wherein a direct current (DC) of 2 mA was administered for 20 minutes (with additional ramp-up and ramp-down phase of 20 seconds each at the beginning and end of the session respectively), adhering to stringent safety measures.

详细描述

As apriori registration was not done before the initiation of the study and all the participants already underwent tDCS intervention, the investigators are herewith submitting the protocol of the study retrospectively following the completion of the project. This study was conducted at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India, with the approval of the NIMHANS Institutional Ethics Committee.

Study Sample: All consenting participants of both sexes (age range: 55 - 84 years) meeting the inclusion and exclusion criteria (see below), who consecutively attended the outpatient services of the Geriatric Clinic and Services (GCS), NIMHANS from August 2019 to December 2022 with memory complaints were recruited in this study with their signed informed consent. Only right-handed individuals were recruited as assessed using the Edinburgh Handedness Inventory (EHI). Participants were screened to ensure that only those with optimal hearing and visual acuity were recruited. The clinical diagnoses of MCI and mild AD made by clinicians at the GCS at NIMHANS were confirmed using the National Institute on Ageing - Alzheimer's Association (NIA-AA) diagnostic criteria and Clinical Dementia Rating [CDR] (CDR scores of 0.5 for MCI and 1 for mild AD). Participants with CDR scores above 1 were excluded from this study. Other exclusion criteria included concurrent medical conditions like hypothyroidism, hypercalcemia, vitamin B12 deficiency, uncontrolled hypertension and diabetes, neurosyphilis, normal pressure hydrocephalus, subdural hematoma, etc., requiring initiation of medical/surgical interventions and/or titration of medications; pre-existing major psychiatric and neurological illnesses, such as schizophrenia spectrum disorders, bipolar affective disorder, major depressive disorder, obsessive-compulsive disorder, substance dependence, intellectual disability disorder, Parkinson's disease and related disorders, stroke, epilepsy, and other chronic neurological/neurodegenerative disorders, and significant head injury; and current usage of antipsychotics, antidepressants, and benzodiazepines. Forty patients (19 MCI and 21 mild AD) consented to participate in the study and completed the tDCS intervention protocol, which comprised daily 20-minute tDCS sessions for 10 days. All participants underwent detailed neuropsychological assessments, resting-state functional magnetic resonance imaging (rsfMRI), task-based functional magnetic resonance imaging (tbfMRI) as well as resting state magnetoencephalography (rsMEG) following tDCS intervention.

Neuropsychological Battery for Elderly (NNB-E): This battery includes tests of episodic memory, executive functions, attention, visuospatial function, and parietal focal signs and required 1.5 hours to administer and score. Assessments were carried out at baseline (pre-tDCS) and after completion of the last tDCS session (post-tDCS). These pre- and post-tDCS assessments were conducted in a way that prevented the same researcher from doing both tests for a particular participant. Additionally, the person conducting the post-tDCS assessment was blind to the results of the pre-assessment. Two different forms were used for the pre-and post-tDCS assessments of a participant to avoid practice effects. Shapiro Wilk test was performed to check the normality distribution of the differences between pre- and post-tDCS scores for each sub-test (n=26) of NNB-E. Accordingly, paired t-tests and Wilcoxon signed rank tests were carried out respectively for normally and non-normally distributed sub-test scores to look for significant effects of tDCS intervention.

Magnetic Resonance Imaging (MRI): The MRIs were acquired on a 3Tesla Philips Ingenia CX (Philips Healthcare, Netherlands) scanner with a 32-channel phased-array head coil. During rs-fMRI acquisition, the participants were instructed to remain physically and mentally relaxed with their eyes open and not focus on anything particular. These functional MR images corresponding to each participant were visually examined for scanner or acquisition-related artifacts. The rs-fMRI data of one participant each from the MCI and mild AD groups showed more than 5% intensity variation in two consecutive volumes indicating poor quality of functional images due to motion artifacts validated using Derivative of root mean square VARiance over voxelS (DVARS). After the exclusion of both pre- and post-rsfMRI scans of these two participants, the data of the remaining 38 participants (n=18 in the MCI group and n=20 in the mild AD group) were further analyzed. The seed for the seed-to-voxel resting state functional connectivity (S2V-rsFC) analysis was set using the Harvard cortical atlas, as the left middle frontal gyrus (lMFG), corresponding to the left DLPFC, the site of the anodal tDCS. The analysis between pre- and post-tDCS intervention was performed using the spherical mask of lMFG as 'seed' and the whole-brain volume for 'voxels'. Two-tailed parametric statistics were implemented to obtain the results using a cluster-level extent threshold (p-FDR corrected) with voxel threshold at p < 0.001 (p-uncorrected) and cluster threshold at p < 0.05 (p-corrected).

A novel episodic memory paradigm, comprising two tasks: an incidental encoding task and an intentional retrieval task, was used for tb-fMRI acquisition. In the incidental encoding task, the participants were instructed on each trial to indicate using a button press whether the presented visual images were of living or non-living objects. In the intentional retrieval task, the instruction for each trial was to indicate using a button press, whether the presented visual images were seen before (memory images, MI) or not seen before (non-memory images, nMI). The optimal number of trials for the incidental encoding task (living objects: 55; non-living objects: 55; fixation cross: 56) and the intentional retrieval task (memory images, MI: 55; non-memory images, nMI: 55; fixation cross: 56) was estimated using the fMRI stimulator to maximize the predictable variance between the three trial classes for each of the two tasks. Only the participants showing more than 60% performance accuracy on both incidental encoding and intentional retrieval were analyzed. Task-based fMRI data pre-processing and analyses of remaining participants with early AD (n=30; MCI=15, mild AD=15) were carried out using FMRI Expert Analysis Tool (FEAT) Version 6.00 of FMRIB Software Library (FSL), implementing high-quality model-based fMRI data analysis. Z (Gaussianised T/F) statistical images were thresholded non-parametrically using clusters determined by Z > 2.3 and a corrected cluster significance threshold of P=0.05.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Elderly aged 55 years or above
  • •Both genders
  • •Only right handed individuals
  • •Elderly with a diagnosis of Minimal Cognitive Impairment and Mild AD according to National institute of Ageing -Alzheimer's Association (NIAAA) diagnostic Criteria and 0.5 for MCI and 1 according to CDR criteria.
  • •Informed consent

排除标准

  • •Elderly with more advanced dementia (CDR >1)
  • •Patients on medications like antipsychotics, antidepressants and benzodiazepines (some of patients).
  • •Patient with comorbid clinical conditions like hypothyroidism, hypercalcemia, vitamin B12 deficiency, niacin deficiency, neurosyphilis, normal pressure hydrocephalus or subdural haematoma.
  • •Persons with other mental disorders like schizophrenia and related disorder, bipolar affective disorder, severe depression, obsessive compulsive disorder, substance dependence and mental retardation.
  • •History of neurological illness like stroke, epilepsy, head injury with significant loss of consciousness or other chronic neurological/ neurodegenerative conditions.
  • •Elderly Cognitively Healthy Comparison group (n=50)
  • •Inclusion criteria
  • •Elderly aged 55 years or above (age, gender and education matched with Dementia subjects)
  • •Persons without MCI/AD (NIAAA Criteria)
  • •Both genders, only right handed individuals.
  • •Informed consent Exclusion criteria
  • •Elderly with MCI or dementia (CDR ≥0.5)
  • •Patients on medications like antipsychotics, antidepressants and benzodiazepines (some of patients).
  • •Patient with comorbid clinical conditions like hypothyroidism, hypercalcemia, vitamin B12 deficiency, niacin deficiency, neurosyphilis, normal pressure hydrocephalus or subdural haematoma.
  • •Persons with other mental disorders like schizophrenia and related disorder, bipolar affective disorder, severe depression, obsessive compulsive disorder, substance dependence and mental retardation.
  • •History of neurological illness like stroke, epilepsy, head injury with significant loss of consciousness or other chronic neurological/ neurodegenerative conditions.

结局指标

主要结局

Magnetic Resonance Imaging

时间窗: After the completion of 10 sessions of tDCS (one session per day) spanning across a maximum of 14 days

The resting state functional connectivity, incidental encoding and intentional retrieval task based activation were the primary outcome measures of MRI.

Magnetoencephalography

时间窗: After the completion of 10 sessions of tDCS (one session per day) spanning across a maximum of 14 days

The power of alpha, beta, theta and gamma bandwidths, phase of theta waves and amplitude of gamma band coupling in the left entorhinal cortex were calculated as primary outcome measure of magnetoencephalography

Cognitive assessments

时间窗: After the completion of 10 sessions of tDCS (one session per day) spanning across a maximum of 14 days

The output of NIMHANS Neuropsychological Battery for Elderly (NNB-E) measuring tests of episodic memory, executive functions, attention, visuospatial function, and parietal focal signs were noted as primary outcome measures of the cognitive assessments used in this study.

次要结局

未报告次要终点

研究者

发起方
National Institute of Mental Health and Neuro Sciences, India
申办方类型
Other
责任方
Principal Investigator
主要研究者

John P John

Professor of Psychiatry

National Institute of Mental Health and Neuro Sciences, India

研究点 (2)

Loading locations...

相似试验